Hank Plain
Director
Business Management
Moximed
Italy
Biography
Mr. Plain joined Morgenthaler Ventures in 2007 after more than 25 years in the life science industry, including co-founding eight medical device start-ups and directing the exits of four companies with a combined value well in excess of $1 billion. Mr. Plain is also the Vice Chairman of The Foundry, a medical device incubator based in Redwood City, California, where he co-founded Ardian, Cabochon Aesthetics, Cierra, Emphasys Medical, ForSight Labs, Satiety, Transcend and Xtent. He is a board member of Access Closure, Acclarent, and Moximed Inc. He served as President and CEO at Perclose, Inc. from 1993 to 2000, during which time he led the company to $100 million in sales and managed the company’s successful IPO and acquisition in 1999 by Abbott Laboratories for $650 million. He was Chairman of Embolic Protection, where he helped negotiate the acquisition of the company in 2001 by Boston Scientific for $200 million. He also served as a Director at TransVascular, Inc. until Medtronic acquired the company in 2003 for an undisclosed amount. Previously, Mr. Plain worked at Eli Lilly for 12 years in various management positions.
Research Interest
Business administration
